Author

Timo Minssen

  • Biotechnology

    The Fight Against Antimicrobial Resistance: Important recent publications

    By Timo Minssen One of my previous blogs discussed the growing threat of antimicrobial resistance (AMR). I concluded that antimicrobial resistance is a growing and complex threat involving multifaceted legal, socio-economic and scientific aspects. This…

    The Fight Against Antimicrobial Resistance: Important recent publications

  • Biotechnology

    Summer Course for Professionals in “Pharma Law & Policy” at the University of Copenhagen

    Stay abreast with recent developments and trends determining the legal and regulatory framework of the European pharmaceutical industry. What are the most significant current issues shaking and shaping the pharmaceutical industry today? The business environment…

    Summer Course for Professionals in “Pharma Law & Policy” at the University of Copenhagen

  • Bioethics

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

    By Timo Minssen Following the approval of the European Parliament (EP) earlier last month, the Council of the European Union (the Council) adopted on 14 April 2014 a “Regulation on clinical trials on medicinal products…

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

  • Biotechnology

    Review of Minssen, “Assessing the Inventiveness of Biopharmaceuticals under the European and U.S. Patent Laws”

    In “The “Problem” with the European Problem/Solution Approach to Inventive Step,” Harold C. Wegner reviews Petrie-Flom Visiting Scholar Timo Minssen‘s doctoral thesis. From the review: Patent applicants seeking to gain global patent protection beyond their…

    Review of Minssen, “Assessing the Inventiveness of Biopharmaceuticals under the European and U.S. Patent Laws”

  • Biotechnology

    Book Review published on SSRN

    By Timo Minssen Three weeks ago I blogged about my recent review of  “Pharmaceutical Innovation, Competition and Patent Law – a Trilateral Perspective” (Edward Elgar 2013). The full review, which is forthcoming in a spring issue of European…

    Book Review published on SSRN

  • Bioethics

    New paper on “Standardization, IPRs and Open Innovation in Synthetic Biology”

    By Timo Minssen I am pleased to announce that we have today published the following paper: Minssen, Timo and Wested, Jakob Blak, Standardization, IPRs and Open Innovation in Synthetic Biology (February 14, 2014). Available at…

    New paper on “Standardization, IPRs and Open Innovation in Synthetic Biology”

  • Generic Drugs

    Speech at US Patent Experts Conference in Naples Florida

    The University of Akron School of Law will host the 2nd Annual Midwinter Patent Experts Conference in Naples, Florida February 10-11, 2014. The conference will be held at the Naples Hilton Hotel. The faculty for…

    Speech at US Patent Experts Conference in Naples Florida

  • Biotechnology

    Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

    By Timo Minssen Following a request by the European Competition Law Review (Sweet Maxwell), I have today submitted a review of the recent publication  “Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective”, edited…

    Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective